Recent studies have shown that I3C-mediated inhibition of WWP1 can restore PTEN stability and suppress tumor progression in MYC-driven cancer models [178], implying how therapeutic targeting of the WWP1-PTEN axis could be effective against a broad spectrum of cancers driven by the MYC oncogene. The gene discussed is WWP1; the disease is cancer.